Newsletter | May 13, 2022

05.13.22 -- AAV Development, Manufacturing: Practical, Innovative Solutions

 
Radiance Label-Free Monitoring Of AAV Transfection In HEK293 Cells
 

LumaCyte’s Radiance® instrument has the potential to improve the characterization of cell-based AAV transfection and production, improving the efficiency and accuracy of both processes and shortening development time.

Manufacturing Innovation Across New Modalities
 

The successful outcomes delivered by cell and gene therapies, coupled with the emergence of modalities across nucleic acid therapeutics and microbiomes, poses the next scalability challenge.

Practical, Innovative Solutions For AAV Development, Manufacturing
 

Explore case studies for neuromuscular degenerative indications, AAV technology and manufacturing, and strategies for navigating the regulatory environments in the U.S. and Europe.

The Journey Into Cell And Gene Therapy
 

Hear about our venture into the development and manufacturing of viral vector gene therapies and how we are overcoming challenges and maintaining our commitment to our partners.